C L Shapiro|D F Hayes - JoVE Visualize

Showing results (61-70 of 121) with videos related to

Pageof 13

Sort By:

Cancer Communications|January 1, 1989

Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell lineS R Hull, A Bright, K L Carraway, et al.

Breast Cancer Research and Treatment|May 27, 2008

Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?S J Beyer, R E Jimenez, C L Shapiro, et al.

Journal of Surgical Oncology|July 1, 1986

The syndrome of inappropriate antidiuretic hormone secretion associated with induction chemotherapy for squamous cell carcinoma of the head and neckD F Hayes, R M Lechan, M R Posner, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001

Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancerP W Kantoff, S Halabi, D A Farmer, et al.

Cancer Research|June 1, 1986

Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancerD F Hayes, M R Zalutsky, W Kaplan, et al.

Cancer|July 21, 1998

The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines?E Guadagnoli, C L Shapiro, J C Weeks, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998

Use of breast-conserving surgery for treatment of stage I and stage II breast cancerE Guadagnoli, J C Weeks, C L Shapiro, et al.

Journal of the National Cancer Institute|March 16, 2000

Association of angiogenesis in lymph node metastases with outcome of breast cancerA J Guidi, D A Berry, G Broadwater, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2013

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumabE M Olson, M Abdel-Rasoul, J Maly, et al.

Cancer Investigation|December 11, 1999

Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patientsC L Shapiro, J Keating, J E Angell, et al.

Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:

Pageof 13

Cancer Communications|January 1, 1989

Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell lineS R Hull, A Bright, K L Carraway, et al.

Breast Cancer Research and Treatment|May 27, 2008

Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?S J Beyer, R E Jimenez, C L Shapiro, et al.

Journal of Surgical Oncology|July 1, 1986

The syndrome of inappropriate antidiuretic hormone secretion associated with induction chemotherapy for squamous cell carcinoma of the head and neckD F Hayes, R M Lechan, M R Posner, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001

Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancerP W Kantoff, S Halabi, D A Farmer, et al.

Cancer Research|June 1, 1986

Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancerD F Hayes, M R Zalutsky, W Kaplan, et al.

Cancer|July 21, 1998

The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines?E Guadagnoli, C L Shapiro, J C Weeks, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998

Use of breast-conserving surgery for treatment of stage I and stage II breast cancerE Guadagnoli, J C Weeks, C L Shapiro, et al.

Journal of the National Cancer Institute|March 16, 2000

Association of angiogenesis in lymph node metastases with outcome of breast cancerA J Guidi, D A Berry, G Broadwater, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2013

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumabE M Olson, M Abdel-Rasoul, J Maly, et al.

Cancer Investigation|December 11, 1999

Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patientsC L Shapiro, J Keating, J E Angell, et al.

Pageof 13